Patrick R. Trucchio
Stock Analyst at HC Wainwright & Co.
(4.60)
# 217
Out of 5,118 analysts
46
Total ratings
60%
Success rate
31.58%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Patrick R. Trucchio
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VIR Vir Biotechnology | Reiterates: Buy | $15 | $5.90 | +154.24% | 2 | Dec 30, 2025 | |
| ASMB Assembly Biosciences | Reiterates: Buy | $50 | $32.99 | +51.56% | 2 | Dec 22, 2025 | |
| NRXP NRx Pharmaceuticals | Reiterates: Buy | $40 | $2.61 | +1,432.57% | 4 | Dec 16, 2025 | |
| MRKR Marker Therapeutics | Initiates: Buy | $10 | $1.53 | +552.74% | 1 | Dec 8, 2025 | |
| PHVS Pharvaris | Reiterates: Buy | $60 | $25.92 | +131.48% | 3 | Dec 3, 2025 | |
| ARWR Arrowhead Pharmaceuticals | Maintains: Buy | $80 → $85 | $66.70 | +27.44% | 3 | Dec 2, 2025 | |
| HRMY Harmony Biosciences Holdings | Reiterates: Buy | $55 | $37.29 | +47.49% | 2 | Nov 24, 2025 | |
| ONCY Oncolytics Biotech | Maintains: Buy | $5 → $10 | $0.89 | +1,026.89% | 1 | Nov 17, 2025 | |
| CYBN Cybin | Maintains: Buy | $150 → $55 | $8.55 | +543.27% | 1 | Nov 14, 2025 | |
| VYGR Voyager Therapeutics | Maintains: Buy | $30 → $25 | $3.93 | +536.13% | 2 | Nov 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $35 | $12.69 | +175.81% | 1 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $70 | $24.31 | +187.95% | 5 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $10 | $2.51 | +298.41% | 3 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $50 | $18.82 | +165.67% | 2 | Oct 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $34.60 | +189.02% | 1 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $3.67 | +226.98% | 2 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $27.44 | +191.55% | 2 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $570 | $394.43 | +44.51% | 2 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $3.99 | +276.41% | 1 | Sep 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 | $6.35 | +1,081.10% | 1 | Sep 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $85 | $78.30 | +8.56% | 2 | Sep 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $50 | $9.60 | +420.83% | 2 | Sep 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $0.41 | +2,350.98% | 1 | Sep 4, 2025 |
Vir Biotechnology
Dec 30, 2025
Reiterates: Buy
Price Target: $15
Current: $5.90
Upside: +154.24%
Assembly Biosciences
Dec 22, 2025
Reiterates: Buy
Price Target: $50
Current: $32.99
Upside: +51.56%
NRx Pharmaceuticals
Dec 16, 2025
Reiterates: Buy
Price Target: $40
Current: $2.61
Upside: +1,432.57%
Marker Therapeutics
Dec 8, 2025
Initiates: Buy
Price Target: $10
Current: $1.53
Upside: +552.74%
Pharvaris
Dec 3, 2025
Reiterates: Buy
Price Target: $60
Current: $25.92
Upside: +131.48%
Arrowhead Pharmaceuticals
Dec 2, 2025
Maintains: Buy
Price Target: $80 → $85
Current: $66.70
Upside: +27.44%
Harmony Biosciences Holdings
Nov 24, 2025
Reiterates: Buy
Price Target: $55
Current: $37.29
Upside: +47.49%
Oncolytics Biotech
Nov 17, 2025
Maintains: Buy
Price Target: $5 → $10
Current: $0.89
Upside: +1,026.89%
Cybin
Nov 14, 2025
Maintains: Buy
Price Target: $150 → $55
Current: $8.55
Upside: +543.27%
Voyager Therapeutics
Nov 12, 2025
Maintains: Buy
Price Target: $30 → $25
Current: $3.93
Upside: +536.13%
Nov 10, 2025
Maintains: Buy
Price Target: $40 → $35
Current: $12.69
Upside: +175.81%
Nov 4, 2025
Maintains: Buy
Price Target: $110 → $70
Current: $24.31
Upside: +187.95%
Nov 3, 2025
Maintains: Buy
Price Target: $5 → $10
Current: $2.51
Upside: +298.41%
Oct 24, 2025
Maintains: Buy
Price Target: $10 → $50
Current: $18.82
Upside: +165.67%
Oct 22, 2025
Reiterates: Buy
Price Target: $100
Current: $34.60
Upside: +189.02%
Oct 20, 2025
Reiterates: Buy
Price Target: $12
Current: $3.67
Upside: +226.98%
Oct 10, 2025
Reiterates: Buy
Price Target: $80
Current: $27.44
Upside: +191.55%
Oct 10, 2025
Reiterates: Buy
Price Target: $570
Current: $394.43
Upside: +44.51%
Sep 23, 2025
Reiterates: Buy
Price Target: $15
Current: $3.99
Upside: +276.41%
Sep 16, 2025
Reiterates: Buy
Price Target: $75
Current: $6.35
Upside: +1,081.10%
Sep 15, 2025
Reiterates: Buy
Price Target: $85
Current: $78.30
Upside: +8.56%
Sep 12, 2025
Reiterates: Buy
Price Target: $50
Current: $9.60
Upside: +420.83%
Sep 4, 2025
Reiterates: Buy
Price Target: $10
Current: $0.41
Upside: +2,350.98%